Which immunonutritional marker best predicts disease-free survival in non-metastatic colorectal Cancer? The CALLY index and CAR emerge as independent predictors from a seven-marker comparison
Frontiers in Nutrition · 18.06.2026 · 13
DOI: 10.3389/fnut.2026.1865242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 18.06.2026. Verfasst von Jong Min Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Many immunonutritional markers (INMs) have emerged as significant prognostic indicators in colorectal cancer (CRC); however, limited attention has been given to directly comparing these candidates to identify the most informative predictors.
Methods
We retrospectively analyzed 414 patients with stage I–III CRC who underwent curative resection. Seven INMs, including the C-reactive protein-albumin-lymphocyte (CALLY) index, the C-reactive protein-to-albumin ratio (CAR), and five other markers, were evaluated. The primary outcome was disease-free survival (DFS). Multivariable Cox proportional hazards regression was performed to identify independent predictors of DFS. The discriminatory performance of the resulting models was quantified using Harrell’s concordance index (C-index).
Results
In univariable analysis, all seven INMs were significantly associated with DFS. However, after adjusting for T and N stages and other covariates, only the CALLY index (HR, 1.686; 95% confidence interval (CI), 1.038–2.738; p = 0.035) and CAR (HR, 2.089; 95% CI, 1.276–3.422; p = 0.004) remained independent predictors. Integrating these markers into the staging system significantly enhanced predictive accuracy. The C-index improved from 0.713 (95% CI, 0.657–0.764) for the stage-only model to 0.812 (95% CI, 0.781–0.867) for the CALLY + stage model and 0.809 (95% CI, 0.779–0.865) for the CAR + stage model.
Conclusion
The CALLY index and CAR were the only INMs that retained independent prognostic significance after adjustment for T and N stages. Incorporating these continuous markers into the Tumor-Node-Metastasis (TNM) staging system substantially improved risk stratification and predictive accuracy in patients with non-metastatic CRC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.
Zitieren
APA
Lee, J. M., Kim, T., & Kim, N. K. (2026). Which immunonutritional marker best predicts disease-free survival in non-metastatic colorectal Cancer? The CALLY index and CAR emerge as independent predictors from a seven-marker comparison. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1865242
Vancouver
Lee JM, Kim T, Kim NK. Which immunonutritional marker best predicts disease-free survival in non-metastatic colorectal Cancer? The CALLY index and CAR emerge as independent predictors from a seven-marker comparison. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1865242
BibTeX
@article{Lee2026,
author = {Lee, Jong Min and Kim, Taehyung and Kim, Nam Kyu},
title = {Which immunonutritional marker best predicts disease-free survival in non-metastatic colorectal Cancer? The CALLY index and CAR emerge as independent predictors from a seven-marker comparison},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1865242}
}
EUVIMED